PDLIM7 and nasopharyngeal carcinoma: This observation probably reflects Yu103 EBV's provenance from NPC but may also account for its epithelial cell-transforming powers, since the targets of BART miRNAs include LMP1 and other putative gene products that may be critical to preventing the eviction of the EBV episomal genome from host epithelial cells (54, 55).